Therapeutic Drug Monitoring Industry Research Report 2023

August 2023 | 89 pages | ID: T3392979495FEN
APO Research

Abstracts

This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring.

The Therapeutic Drug Monitoring market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Therapeutic Drug Monitoring market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Drug Monitoring companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

• Roche
• Danaher
• Abbott
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• BioMerieux
• Sanquin
• Becton Dickinson
• Quest Diagnostics

Product Type Insights

Global markets are presented by Therapeutic Drug Monitoring type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Therapeutic Drug Monitoring are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

Therapeutic Drug Monitoring segment by Type

• Blood Test
• Urine Test
• Saliva Test
• Other Test

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the Therapeutic Drug Monitoring market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Therapeutic Drug Monitoring market.

Therapeutic Drug Monitoring Segment by Application

• Hospital Labs
• Private Labs
• Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Therapeutic Drug Monitoring market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Therapeutic Drug Monitoring industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Therapeutic Drug Monitoring companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

Contents

1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Therapeutic Drug Monitoring by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
  1.2.2 Blood Test
  1.2.3 Urine Test
  1.2.4 Saliva Test
  1.2.5 Other Test
2.3 Therapeutic Drug Monitoring by Application
  2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
  2.3.2 Hospital Labs
  2.3.3 Private Labs
  2.3.4 Others
2.4 Assumptions and Limitations

3 THERAPEUTIC DRUG MONITORING BREAKDOWN DATA BY TYPE

3.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2018-2023)
3.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2023-2028)

4 THERAPEUTIC DRUG MONITORING BREAKDOWN DATA BY APPLICATION

4.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2018-2023)
4.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2018-2023)

5 GLOBAL GROWTH TRENDS

5.1 Global Therapeutic Drug Monitoring Market Perspective (2018-2029)
5.2 Global Therapeutic Drug Monitoring Growth Trends by Region
  5.2.1 Global Therapeutic Drug Monitoring Market Size by Region: 2018 VS 2022 VS 2029
  5.2.2 Therapeutic Drug Monitoring Historic Market Size by Region (2018-2023)
  5.2.3 Therapeutic Drug Monitoring Forecasted Market Size by Region (2024-2029)
5.3 Therapeutic Drug Monitoring Market Dynamics
  5.3.1 Therapeutic Drug Monitoring Industry Trends
  5.3.2 Therapeutic Drug Monitoring Market Drivers
  5.3.3 Therapeutic Drug Monitoring Market Challenges
  5.3.4 Therapeutic Drug Monitoring Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Therapeutic Drug Monitoring Players by Revenue
  6.1.1 Global Top Therapeutic Drug Monitoring Players by Revenue (2018-2023)
  6.1.2 Global Therapeutic Drug Monitoring Revenue Market Share by Players (2018-2023)
6.2 Global Therapeutic Drug Monitoring Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Therapeutic Drug Monitoring Head office and Area Served
6.4 Global Therapeutic Drug Monitoring Players, Product Type & Application
6.5 Global Therapeutic Drug Monitoring Players, Date of Enter into This Industry
6.6 Global Therapeutic Drug Monitoring Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Therapeutic Drug Monitoring Market Size (2018-2029)
7.2 North America Therapeutic Drug Monitoring Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Therapeutic Drug Monitoring Market Size by Country (2018-2023)
7.4 North America Therapeutic Drug Monitoring Market Size by Country (2024-2029)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Therapeutic Drug Monitoring Market Size (2018-2029)
8.2 Europe Therapeutic Drug Monitoring Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Therapeutic Drug Monitoring Market Size by Country (2018-2023)
8.4 Europe Therapeutic Drug Monitoring Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Therapeutic Drug Monitoring Market Size (2018-2029)
9.2 Asia-Pacific Therapeutic Drug Monitoring Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2018-2023)
9.4 Asia-Pacific Therapeutic Drug Monitoring Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Therapeutic Drug Monitoring Market Size (2018-2029)
10.2 Latin America Therapeutic Drug Monitoring Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Therapeutic Drug Monitoring Market Size by Country (2018-2023)
10.4 Latin America Therapeutic Drug Monitoring Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Therapeutic Drug Monitoring Market Size (2018-2029)
11.2 Middle East & Africa Therapeutic Drug Monitoring Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2018-2023)
11.4 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 Roche
  11.1.1 Roche Company Detail
  11.1.2 Roche Business Overview
  11.1.3 Roche Therapeutic Drug Monitoring Introduction
  11.1.4 Roche Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.1.5 Roche Recent Development
11.2 Danaher
  11.2.1 Danaher Company Detail
  11.2.2 Danaher Business Overview
  11.2.3 Danaher Therapeutic Drug Monitoring Introduction
  11.2.4 Danaher Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.2.5 Danaher Recent Development
11.3 Abbott
  11.3.1 Abbott Company Detail
  11.3.2 Abbott Business Overview
  11.3.3 Abbott Therapeutic Drug Monitoring Introduction
  11.3.4 Abbott Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
  11.4.1 Thermo Fisher Scientific Company Detail
  11.4.2 Thermo Fisher Scientific Business Overview
  11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Introduction
  11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthcare
  11.5.1 Siemens Healthcare Company Detail
  11.5.2 Siemens Healthcare Business Overview
  11.5.3 Siemens Healthcare Therapeutic Drug Monitoring Introduction
  11.5.4 Siemens Healthcare Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.5.5 Siemens Healthcare Recent Development
11.6 Bio-Rad Laboratories
  11.6.1 Bio-Rad Laboratories Company Detail
  11.6.2 Bio-Rad Laboratories Business Overview
  11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Introduction
  11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.6.5 Bio-Rad Laboratories Recent Development
11.7 BioMerieux
  11.7.1 BioMerieux Company Detail
  11.7.2 BioMerieux Business Overview
  11.7.3 BioMerieux Therapeutic Drug Monitoring Introduction
  11.7.4 BioMerieux Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.7.5 BioMerieux Recent Development
11.8 Sanquin
  11.8.1 Sanquin Company Detail
  11.8.2 Sanquin Business Overview
  11.8.3 Sanquin Therapeutic Drug Monitoring Introduction
  11.8.4 Sanquin Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.8.5 Sanquin Recent Development
11.9 Becton Dickinson
  11.9.1 Becton Dickinson Company Detail
  11.9.2 Becton Dickinson Business Overview
  11.9.3 Becton Dickinson Therapeutic Drug Monitoring Introduction
  11.9.4 Becton Dickinson Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.9.5 Becton Dickinson Recent Development
11.10 Quest Diagnostics
  11.10.1 Quest Diagnostics Company Detail
  11.10.2 Quest Diagnostics Business Overview
  11.10.3 Quest Diagnostics Therapeutic Drug Monitoring Introduction
  11.10.4 Quest Diagnostics Revenue in Therapeutic Drug Monitoring Business (2017-2022)
  11.10.5 Quest Diagnostics Recent Development

13 REPORT CONCLUSION

14 DISCLAIMER